BCMA/GPRC5D CAR-T cells
/ Essen Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 27, 2025
BAH2573: Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma
(clinicaltrials.gov)
- P1/2 | N=60 | Recruiting | Sponsor: Essen Biotech
New P1/2 trial • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 1
Of
1
Go to page
1